Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adi Vaknin-Dembinsky

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Journal of Neuroimmunology|April 2, 2008
Membrane bound IL-15 is increased on CD14 monocytes in early stages of MSAdi Vaknin-Dembinsky, Steven D Brass, Steven Brass, et al.
Journal of Neuroimmunology|July 10, 2022
IL-6 as a marker for NMOSD disease activityAdi Haramati, Ariel Rechtman, Omri Zveik, et al.
Journal of Neuroimmunology|April 12, 2008
Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosisAdi Vaknin-Dembinsky, Gopal Murugaiyan, David A Hafler, et al.
Journal of Neurology|September 4, 2024
Correction to: Assessing the applicability of the 2023 international MOGAD panel criteria in real-world clinical settingsAriel Rechtman, Tal Friedman-Korn, Omri Zveik, et al.
Journal of Neurology|May 29, 2024
Assessing the applicability of the 2023 international MOGAD panel criteria in real-world clinical settingsAriel Rechtman, Tal Freidman-Korn, Omri Zveik, et al.
Multiple Sclerosis and Related Disorders|September 11, 2025
A predictive model for triple negative optic neuritis patients: Identifying the subset of patients with favorable outcomesAriel Rechtman, Tal Friedman-Korn, Sol Zamir, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 18, 2015
Sex-specific prediction of interferon beta therapy response in relapsing-remitting multiple sclerosisHanna Charbit, Arriel Benis, Bella Geyshis, et al.
Annals of Neurology|November 10, 2010
Interferon-β inhibits toll-like receptor 9 processing in multiple sclerosisKonstantin E Balashov, Latt Latt Aung, Adi Vaknin-Dembinsky, et al.
Journal of Neuroimmunology|January 18, 2015
Dysregulated production of leukemia inhibitory factor in immune cells of relapsing remitting multiple sclerosis patientsYifat Amir Levy, Karin Mausner-Fainberg, Adi Vaknin-Dembinsky, et al.
Multiple Sclerosis and Related Disorders|December 14, 2019
QKI-V5 is downregulated in CNS inflammatory demyelinating diseasesIris Lavon, Ina Leykin, Hanna Charbit, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Journal of Neuroimmunology|April 2, 2008
Membrane bound IL-15 is increased on CD14 monocytes in early stages of MSAdi Vaknin-Dembinsky, Steven D Brass, Steven Brass, et al.
Journal of Neuroimmunology|July 10, 2022
IL-6 as a marker for NMOSD disease activityAdi Haramati, Ariel Rechtman, Omri Zveik, et al.
Journal of Neuroimmunology|April 12, 2008
Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosisAdi Vaknin-Dembinsky, Gopal Murugaiyan, David A Hafler, et al.
Journal of Neurology|September 4, 2024
Correction to: Assessing the applicability of the 2023 international MOGAD panel criteria in real-world clinical settingsAriel Rechtman, Tal Friedman-Korn, Omri Zveik, et al.
Journal of Neurology|May 29, 2024
Assessing the applicability of the 2023 international MOGAD panel criteria in real-world clinical settingsAriel Rechtman, Tal Freidman-Korn, Omri Zveik, et al.
Multiple Sclerosis and Related Disorders|September 11, 2025
A predictive model for triple negative optic neuritis patients: Identifying the subset of patients with favorable outcomesAriel Rechtman, Tal Friedman-Korn, Sol Zamir, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 18, 2015
Sex-specific prediction of interferon beta therapy response in relapsing-remitting multiple sclerosisHanna Charbit, Arriel Benis, Bella Geyshis, et al.
Annals of Neurology|November 10, 2010
Interferon-β inhibits toll-like receptor 9 processing in multiple sclerosisKonstantin E Balashov, Latt Latt Aung, Adi Vaknin-Dembinsky, et al.
Journal of Neuroimmunology|January 18, 2015
Dysregulated production of leukemia inhibitory factor in immune cells of relapsing remitting multiple sclerosis patientsYifat Amir Levy, Karin Mausner-Fainberg, Adi Vaknin-Dembinsky, et al.
Multiple Sclerosis and Related Disorders|December 14, 2019
QKI-V5 is downregulated in CNS inflammatory demyelinating diseasesIris Lavon, Ina Leykin, Hanna Charbit, et al.
Pageof 10